Itamar names president for US market

Tuesday, October 20, 2020

CAESAREA, Israel – Itamar Medical has appointed Shane Brown as president-U.S. effective immediately. In this role, he will oversee commercial strategy and execution in the U.S. as the company plans to further accelerate its investment in penetrating that market. Brown brings more than 20 years of commercial experience to the position, including leading the early adoption of emerging therapies in the medical device, digital health and medtech markets. Most recently, he served as vice president, enterprise accounts at Abbott Laboratories. “Itamar’s recent growth has largely been driven by strength in our U.S. core sleep business, as sleep centers continue to adopt our WatchPAT ONE product,” said Gilad Glick, president and CEO of Itamar Medical. “We’re confident that Shane’s rich experience and success in growing commercial organizations in the cardiology medical technology sector will provide us with further leverage and focus, as we seek to expand our reach to the estimated 54 million to 60 million adults living in the U.S. suffering from sleep apnea.”